A drug used to treat deadly coronavirus infections in cats could potentially be an effective treatment against SARS-CoV-2, the virus behind the global coronavirus pandemic, according to a study.
The finding, published in the journal Nature Communications, paves the way for human clinical trials of the drug, a protease inhibitor called GC376.
"This drug is very likely to work in humans, so we are encouraged that it will be an effective treatment for COVID-19 patients," said Joanne Lemieux, a professor at the University of Alberta in Canada.
However, the researchers said clinical trials will need to run their course before anyone can be